The Impact of Immune System Aging on Infectious Diseases

Eugenia Quiros-Roldan is an Associate Professor of Infectious Diseases at the University of Brescia. He completed his PhD studies in Medicine and Surgery at the University of Brescia in 1990. He is also a member of the scientific secretariat of the MASTER cohort: standardized management of antiretroviral therapy. Prof. Eugenia Quiros-Roldan’s research interests mainly include inflammation and cancer.

Dr. Alessandra Sottini is a Biologist at the Oncohematology Laboratory, Clinical Chemistry Laboratory, Services Department, ASST Spedali Civili of Brescia, Italy. Dr. Alessandra Sottini completed her PhD studies at the Scuola di Specialità in Biochimica e Chimica Clinica, Università degli Studi di Brescia. Since February 2011, Dr. Alessandra Sottini has been working at the Clinical Chemistry Laboratory. Her primary research focuses on translational research, with a special emphasis on the biology and management of human primary and secondary immunodeficiencies, as well as advancements in multiple sclerosis pathogenesis. She has been part of a team dedicated to the development of personalized medicine in hematological and oncological disorders.

Pier Giorgio Natali received his MD degree from “La Sapienza” University in Rome and completed his education with diplomas from ECFMG and the Board of American Medical Laboratory Immnunology, and advanced training in Immunopathology at The Scripps Clinic Research Fnd., San Diego, USA. He joined the “Regina Elena” National Cancer Institute in the early 1970s, the oldest (1935) Comprehensive Cancer Center in Italy. As Scientific Director (1995–2001) of the “Regina Elena” Institute, he strongly supported “intra moenia” and territorial prevention activities, launching a massive program for the prevention of sunlight-related risks in regional elementary schools, which was later adopted and awarded internationally. He initiated the activities of the first Italian center for prevention of oral cavity tumors in a comprehensive cancer center. He has been President of the Italian Cancer Society. He has chaired the Early Tumor Diagnosis Program Team of the Italian League Against Cancer, and is now Secretary General of the Mediterranean Task Force for Cancer Control (www-mtcc-prevention.org). He belongs to the Advisory Board of the “Cancer Today Magazine”, edited by the American Association for Cancer Research, addressing public awareness, advocacy and cancer survivor issues. For his achievements, he received an Honorary Degree in Immunology from the University of Pecs.

Dr. Luisa Imberti was a senior researcher at the Clinical Chemistry Section, Main Hospital of Brescia, Italy. She received her degree in Medicine and Surgery from the University of Milan, Italy, in 1981. Her postgraduate specialization in 1991 was in Biochemistry, and in 2001 in Allergology and Clinical Immunology from the University of Brescia, Italy. Her main research activity is in the field of translational research, with a special contribution in the biology and management of primary and secondary human immunodeficiencies, in the pathogenesis of multiple sclerosis and, recently, of COVID-19.